Introduction
This article serves as a formal correction to a previously published study in Cancer Cell International. The primary objective of this erratum is to rectify a graphical error in the original publication, specifically regarding the representation of cell proliferation data. Despite the technical nature of this update, the underlying research provides significant insights into the HGF/c-MET signaling pathway's role in oncogenesis.
The Role of HGF/c-MET in Tumor Progression
The HGF/c-MET signaling pathway is a critical driver of tumor growth, survival, and metastasis across various malignancies. The original study investigated how the activation of this pathway influences immune regulation and its potential as a model for tumor diagnosis. The research specifically focused on lung cancer (A549, H460) and esophageal cancer (EC109, KYSE450) cell lines.
Experimental Methodology
To evaluate the impact of the HGF/c-MET pathway, researchers employed gene silencing (knockdown) techniques. The efficacy of these interventions was assessed using several molecular biology assays:
- qRT-PCR: Verified the successful reduction of HGF and c-MET expression.
- CCK8 Assay: Measured cell proliferation rates over a 72-hour period.
- Colony Formation Assay: Evaluated long-term reproductive integrity and the ability of cells to form colonies.
- Scratch Test (Wound Healing Assay): Assessed the migratory and invasive potential of the cancer cells.
Corrected Proliferation Data
The core of this correction involves Figure 10c, which displays the results of the CCK8 assay. The corrected data demonstrates a significant divergence in growth curves between the control and experimental groups.
As shown in the H460 cell line data, silencing either HGF (the ligand) or c-MET (the receptor) leads to a marked reduction in optical density (OD) values over time compared to the negative control (NC) group. This indicates a substantial inhibition of cell growth.
Similarly, in A549 lung cancer cells, the knockdown of these genes resulted in a statistically significant ($p < 0.01$) decrease in proliferation. These corrected figures reinforce the study's conclusion that the HGF/c-MET pathway is essential for maintaining the aggressive growth characteristics of these tumor cells.
Impact on Invasion and Colony Formation
Beyond simple proliferation, the study found that silencing the HGF/c-MET pathway significantly impaired other hallmarks of cancer:
- Colony Formation: There was a visible reduction in the number of colonies formed, suggesting a loss of long-term survival capacity.
- Cell Motility: Scratch tests revealed that silenced cells migrated much more slowly than control cells, confirming the pathway's role in driving invasion and metastasis.
Conclusion
The correction of Figure 10c ensures that the scientific record accurately reflects the experimental findings. The data confirms that targeting the HGF/c-MET pathway significantly inhibits the "fitness" of lung and esophageal cancer cells, supporting its potential as both a diagnostic marker and a therapeutic target.
Summary updated